Document is current

Article History

Received: 15 April 2024

Accepted: 14 November 2025

First Online: 24 November 2025

Declarations

:

: The study protocol was approved by the Institutional Review Board of Chung-Ang University Hospital (approval number: 2311-005-577). Adverse events will be recorded and reported to relevant bodies according to the guidelines of the Chung-Ang University Hospital Institutional Review Board. Changes in the protocol will be confirmed by the Institutional Review Board before being applied to the trial. All participants will provide written informed consent prior to participation. Informed written consent will be obtained by the primary researcher and other researchers deemed fit by the Institutional Review Board. The clinical trial was registered with the Clinical Research Information Service, a part of the WHO International Clinical Trials Registry Platform, on March 5, 2024 (approval number: KCT0009219).All procedures contributing to this work comply with the ethical standards of the Korean Association of Institutional Review Boards and the Helsinki Declaration of 1975, as revised in 2008. Patient information will be protected in accordance with the guidelines approved by the Chung-Ang University Hospital Institutional Review Board and relevant legislation. The results of this study will be published in a timely manner in an appropriate journal. Currently, no information regarding the results of this study has been published or submitted elsewhere.

: Not applicable.

: The authors declare no competing interests.